Clinical trial
Treatment of Autism in Children and Adolescents
NCT00005014 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00005014 |
|---|---|
| Title | Treatment of Autism in Children and Adolescents |
| Official title | Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Autistic Disorder |
| Intervention type | Drug |
| Interventions | Risperidone |
| Enrollment | 101 |
| Start date | Oct 1, 1997 |
| Completion | Feb 1, 2001 |
| First posted | Apr 3, 2000 |
| Last update posted | Apr 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: